6 February 2020
\n \n \n \nCongratulations to Prof Kristijan Ramadan who has been awarded a three year research grant from Breast Cancer Now. The grant will support Dr. Abhay Narayan Singh who will explore new ways to use chemotherapy in order to improve the outcomes for women with breast cancer.
\n \n\n \n \n4 February 2020
\n \n \n \nTuesday 4 Feb 2020 is World Cancer Day (https://www.worldcancerday.org/).\r\n\r\nLed by the Union for International Cancer Control, the day aims to raise awareness and education about cancer.
\n \n\n \n \n4 November 2019
\n \n \n \nThe NIHR has invested \u00a334 million of funding into global health research projects to tackle epilepsy, infection-related cancers and severe stigmatising skin diseases in low- and middle-income countries (LMICs).
\n \n\n \n \n15 October 2019
\n \n \n \nKristijan Ramadan and his group published a new article in The EMBO Journal today. The article adds new detail to the story of how our cells repair damage to our DNA.
\n \n\n \n \n20 September 2019
\n \n \n \nThe Department of Oncology has signed up to collaborate with Crescendo Biologics Ltd (Crescendo), the drug developer of novel, targeted T cell enhancing therapeutics.
\n \n\n \n \n17 September 2019
\n \n \n \nOn 14 September, the Old Road Campus joined the 2019 Oxford Open Doors event and welcomed the public into our workplace.
\n \n\n \n \n8 August 2019
\n \n \n \nThe new 7-year research collaboration with Janssen Research & Development, LLC (Janssen) will study patients at higher risk of developing certain types of blood cancers that arise from the immune system, such as chronic lymphocytic leukaemia and multiple myeloma, to identify markers that could be used to predict who will go on to develop symptomatic disease.
\n \n\n \n \n25 July 2019
\n \n \n \nMadalena Tarsounas' group have recently published two new papers in EMBO Molecular Medicine and Nature Communications.
\n \n\n \n \n18 July 2019
\n \n \n \nKristijan Ramadan's group have published a new paper which shows how cells keep the DNA replication machinery moving when faced with blockers.
\n \n\n \n \n25 March 2019
\n \n \n \nResearch by the DNA Damage & Disease research group has for the first time observed molecular fibres that may hold together sections of broken DNA in mitosis.
\n \n\n \n \n12 February 2019
\n \n \n \nResearchers in Oxford have found that an individual\u2019s immune system \u2013 and in particular the presence of T-cells amongst tumour cells - may play an important role in survival after surgery to remove pancreatic cancer.
\n \n\n \n \n7 February 2019
\n \n \n \nGenesisCare and the University of Oxford establish innovative 10-year research partnership to improve diagnosis and care for people with cancer.
\n \n\n \n \n24 January 2019
\n \n \n \nThe Department of Oncology is pleased to announce that Professor Amato J Giaccia has been appointed as the new Director of the MRC Oxford Institute for Radiation Oncology (OIRO).
\n \n\n \n \n30 November 2018
\n \n \n \nResearchers in the Department of Oncology have secured funding to characterise an insulin-like growth factor (IGF) signature for early detection and risk reduction of cancer.
\n \n\n \n \n26 November 2018
\n \n \n \nScientists from the Department of Oncology have equipped a virus that kills carcinoma cells with a protein so it can also target and kill adjacent cells that are tricked into shielding the cancer from the immune system.
\n \n\n \n \n6 November 2018
\n \n \n \nGreg Clark, UK Secretary of State for Business, Energy and Industrial Strategy (BEIS), will confirm today (Tuesday 6 November) that UK Research and Innovation will invest \u00a310million in the National Consortium of Intelligent Medical Imaging (NCIMI), to be led from Oxford University as part of the Industrial Strategy Challenge Fund.
\n \n\n \n \n28 September 2018
\n \n \n \nCongratulations to Dr Serena Lucotti, who has been awarded 'Italy Made Me' prize for her DPhil project.
\n \n\n \n \n12 July 2018
\n \n \n \nThe 6th Annual Oncology Student Symposium was held at St Anne\u2019s College, for the second time, on Monday, 9 July.
\n \n\n \n \n10 April 2018
\n \n \n \nCongratulations to Dr Xiao Wan from Professor Eric O\u2019Neill\u2019s group for her success in obtaining an NC3Rs Training Fellowship for \u2018Developing human organotypic perfused bioreactors for physiologically reproducible therapeutic compound screening of a tumour microenvironment\u2019.
\n \n\n \n \n6 April 2018
\n \n \n \nCongratulations to Dr Bart Cornelissen of the CRUK/MRC Oxford Institute for Radiation Oncology, Department of Oncology who has secured a \u00a3200k grant from UK medical research charity, Pancreatic Cancer Research Fund (PCRF).
\n \n\n \n \n